Cell Impact and NKC sign MoU
Cell Impact AB and the Japanese industrial group Nakanishi Metal Works Co. Ltd. (NKC) have signed an MoU to focus on international business development.
Cell Impact AB and the Japanese industrial group Nakanishi Metal Works Co. Ltd. (NKC) have signed an MoU to focus on international business development.
Nuvera Fuel Cells, LLC, a provider of fuel cell power solutions for motive applications, has completed alpha testing for its Nuvera® 45 kW Fuel Cell Engine.
The Force VII, a racing car developed by students from Delft University of Technology (TU Delft), has been recognised as the first ever hydrogen racing car to secure a podium place in an official race.
With several hydrogen-powered vehicles already available on the market and almost every major car manufacturer planning to launch a range of hydrogen powered vehicles for personal use, it seems as though hydrogen really is the...
In part two of an exclusive three-part series, H2 View goes behind the wheel of a hydrogen fuel cell car with Lawrence Livermore National Laboratory scientist Tadashi Ogitsu.
The Queensland Government is adding hydrogen-powered cars to its fleet in a bid to accelerate the Australian state’s drive towards a hydrogen-fuelled future.
Hydrogen Council member Hyundai Motor Group yesterday unveiled its vision for a global hydrogen society through an exhibition hall dedicated to hydrogen fuel cell vehicles and related technologies in Shanghai, China.
In part one of an exclusive three-part series, H2 View goes behind the wheel of a hydrogen fuel cell car with retired former California Energy Commission attorney Raoul Renaud.
Today’s Science and Technology Select Committee report on clean growth in the UK is comprehensive and welcomed, but the onus now is surely on greater and more accelerated action than it is on further deliberation,...
The global hydrogen industry is stronger than ever before, and the market has realised that hydrogen is the most efficient zero-emission energy alternative, says Hexagon Purus President Dr. Michael Kleschinski in an interview with H2...